Capivasertib FDA approval date

The FDA approved Capivasertib (TRUQAP) on 16 Nov 2023.

FDA approval date
16 Nov 2023

Drug identity checked against registry records

Also recorded as TRUQAP

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-11-16DayCapivasertibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA218197", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["TRUQAP"], "active_ingredients": ["CAPIVASERTIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20231116", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026